In the positive‐ITGB1 expression group, IL‐10 expression was detected in 80.6% (25/31) of tumor cells, whereas in the negative‐ITGB1 expression group, only 28.6% (6/21) of tumor cells showed IL‐10 expression (p < 0.001). This evidence concerns the gene IL10 and neoplasm.